Previous studies have investigated the association of LP
and dyslipidemia. This association was first reported in a
case–control study by Dreiher et al. [7], who found that LP
patients had increased dyslipidemia. However, no information
was provided concerning patients’ lipid levels, use
of lipid-lowering drugs and whether or not patients
received systemic therapy for LP [7]. In 2011, Arias-Santiago
et al. assessed the association between LP and dyslipidemia
and determined a significantly increased rate in
the patient group [8]. In 2012, Lopez-Jornet et al. reported
similar serum total cholesterol, TG and LDL-C levels
between patients with oral LP and the control group, while HDL-C levels were significantly lower in the patient group
[26]. In contrast to these reports, our study determined no
significant increase in the prevalence of dyslipidemia in LP
patients.